A significant advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of https://mysocialfeeder.com/story6880484/nanobodies-revive-tumor-suppressor-p53-new-promising-pathway-for-cancer-management